The chip-in-a-pill combines antipsychotic Abilify with an ingestible sensor made by Proteus.
Jim Caggiano had witnessed Provenge's birth during an earlier turn at Dendreon and couldn't understand what went wrong.
Pfizer to provide Ibrance for free during NICE analysis; the FDA approves new ALS drug; people turn to Twitter to tell stories about pre-existing conditions
Execs stressed the importance of collaboration, consumer-mindedness.
Researchers still don't know why Americans who are prescribed a prescription drug to treat a chronic condition or disease so often fail to fill those prescriptions.
Makers of biosimilars have targeted a few of the top-selling autoimmune drugs. Get ready for some of the highest-stakes pricing and access skirmishes in recent pharma history.
AbbVie's Humira tops the list, according to data compiled by EvaluatePharma.
The research found a reduction in utilization of medications used to treat depression, nausea, and psychosis when looking at data for Medicaid beneficiaries.
How are pharma, clinical, and startup execs addressing some of the biggest challenges facing their businesses today?
A tool kit of pharma case studies and advice for healthcare brands in making behavioral science a foundational part of a marketing strategy.
- Study: One-third of docs trust pharma content on HCP sites
- Five things for pharma marketers to know: Wednesday, May 17, 2017
- Five things for pharma marketers to know: Monday, May 22, 2017
- Five things for pharma marketers to know: Tuesday, May 23, 2017
- Five things for pharma marketers to know: Friday, May 19, 2017